Advanced Filters
noise

A, Almada N Clinical Trials

A listing of A, Almada N clinical trials actively recruiting patients volunteers.

Found 10,668 clinical trials
K Kirsten Dorans, ScD

Strategies for Implementing a Postpartum Lifestyle Intervention in WIC Clinics

The primary objective of the STRIVE study is to compare two implementation strategies for Diabetes Prevention Program delivery: an in-person health coach strategy (standard 24 in-person sessions at WIC clinics) vs. a multifaceted technology-assisted health coach implementation strategy (12 in-person sessions at WIC clinics supplemented by technology support) on implementation …

18 years of age Female Phase N/A
J Jean Yves ROTGE, Pr

Relevance of a Telemedicine Monitoring in the Management of Depression

Major depressive disorder (MDD) is a common chronic disease. It is the main cause of morbidity and disability in the world with, among other things, an increase in cardio-metabolic risk and a reduction in life expectancy, regardless of suicide risk. MDD is the most expensive medical condition: 10-20 billion €/year …

18 years of age All Phase N/A
S Shiraz Hashmi, Masters in public health

Implementing a Multi-component Hypertension Control Strategy in Rural Pakistan

This is a research about cardiovascular disease risk reduction: a comprehensive package for the reduction of risk in Sindh, Pakistan. The research is being conducted by the Aga Khan University and is funded by the National Institute of Health and Care Research UK. Hypertension is a major public health concern …

35 years of age All Phase N/A
S Sarah M Farthing, MS

Advancing Water Security: A Community Participatory School-Based Hydration Intervention

The goal of this study is to determine the effectiveness and sustainability of a community-participatory hydration intervention over 3 years within a district that has newly installed hydration stations and is operating under a policy designed to enhance heathy hydration practices and promote equitable access to drinking water.

4 years of age All Phase N/A
C Camilla T Bonnesen, Researcher

The Bloom Study - a Safe and Healthy Start in Life

The aim of the Bloom Study is to promote healthy weight development among infants through a home-based health promoting intervention implemented in the Danish setting of community health nurses. The intervention begins during pregnancy and runs until the child reaches the age of 30 months. The Bloom Intervention was developed …

- 6 years of age All Phase N/A
C Chen-Yu Huang

A Multi-language Smartphone-based Healthy Lifestyle Intervention for Firefighters

The goal of this cluster randomized controlled trial is to evaluate the effects of a smartphone-based Healthy Lifestyle (HLS) intervention on firefighters' mental and physical health in firefighters in Tainan, Taiwan. The main questions it aims to answer are: Does the Traditional Chinese version of the HLS mobile App improve …

20 years of age All Phase N/A

A Study of Obexelimab in Patients with Systemic Lupus Erythematosus

This study aims to examine the efficacy and safety of obexelimab in participants with systemic lupus erythematosus (SLE).

18 - 70 years of age All Phase 2
C Clémentine GONTHIER, PhD

Host Genome Methylation: a Screening Tool in Anal Cancer Detection

In January 2023, the first recommendations for anal cancer screening were issued by the French National Society of Coloproctology (SNFCP). These were the world's first national recommendations for anal cancer screening for at-risk patients, not limited to people living with HIV. They are based on screening for papillomavirus type 16 …

18 years of age All Phase N/A

A Study of BGM0504 in Participants with Type 2 Diabetes

This trial is conducted in China. The aim of the trial is to evaluate the efficacy and safety of BGM0504 versus semaglutide as add-on to metformin and/or sulfonylureas in patients with type 2 diabetes

18 - 75 years of age All Phase 3

A Trial to Investigate Benralizumab in Children With Eosinophilic Diseases

The main purpose of study is to assess the safety, tolerability, and pharmacokinetic (PK) of benralizumab.

6 - 17 years of age All Phase 3

Simplify language using AI